Your browser doesn't support javascript.
loading
Endothelin-1, Outcomes in Patients With Heart Failure and Reduced Ejection Fraction, and Effects of Dapagliflozin: Findings From DAPA-HF.
Yeoh, Su Ern; Docherty, Kieran F; Campbell, Ross T; Jhund, Pardeep S; Hammarstedt, Ann; Heerspink, Hiddo J L; Jarolim, Petr; Køber, Lars; Kosiborod, Mikhail N; Martinez, Felipe A; Ponikowski, Piotr; Solomon, Scott D; Sjöstrand, Mikaela; Bengtsson, Olof; Greasley, Peter J; Sattar, Naveed; Welsh, Paul; Sabatine, Marc S; Morrow, David A; McMurray, John J V.
Affiliation
  • Yeoh SE; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, United Kingdom (S.E.Y., K.F.D., R.T.C., P.S.J., N.S., P.W., J.J.V.M.).
  • Docherty KF; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, United Kingdom (S.E.Y., K.F.D., R.T.C., P.S.J., N.S., P.W., J.J.V.M.).
  • Campbell RT; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, United Kingdom (S.E.Y., K.F.D., R.T.C., P.S.J., N.S., P.W., J.J.V.M.).
  • Jhund PS; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, United Kingdom (S.E.Y., K.F.D., R.T.C., P.S.J., N.S., P.W., J.J.V.M.).
  • Hammarstedt A; BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden (A.H., M.S., O.B., P.J.G.).
  • Heerspink HJL; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, The Netherlands (H.J.L.H.).
  • Jarolim P; George Institute for Global Health, University of New South Wales, Sydney, Australia (H.J.L.H.).
  • Køber L; Department of Pathology (P.J.), Brigham and Women's Hospital, Boston, MA.
  • Kosiborod MN; Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Denmark (L.K.).
  • Martinez FA; Saint Luke's Mid America Heart Institute, University of Missouri, Kansas City (M.N.K.).
  • Ponikowski P; Universidad Nacional de Córdoba, Argentina (F.A.M.).
  • Solomon SD; Center for Heart Diseases, University Hospital, Wroclaw Medical University, Poland (P.P.).
  • Sjöstrand M; Division of Cardiovascular Medicine (S.D.S.), Brigham and Women's Hospital, Boston, MA.
  • Bengtsson O; BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden (A.H., M.S., O.B., P.J.G.).
  • Greasley PJ; Thrombolysis in Myocardial Infarction Study Group (M.S.S., D.A.M.), Brigham and Women's Hospital, Boston, MA.
  • Sattar N; BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden (A.H., M.S., O.B., P.J.G.).
  • Welsh P; BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden (A.H., M.S., O.B., P.J.G.).
  • Sabatine MS; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, United Kingdom (S.E.Y., K.F.D., R.T.C., P.S.J., N.S., P.W., J.J.V.M.).
  • Morrow DA; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, United Kingdom (S.E.Y., K.F.D., R.T.C., P.S.J., N.S., P.W., J.J.V.M.).
Circulation ; 147(22): 1670-1683, 2023 05 30.
Article in En | MEDLINE | ID: mdl-37039015
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ventricular Dysfunction, Left / Heart Failure Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Humans / Male Language: En Journal: Circulation Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ventricular Dysfunction, Left / Heart Failure Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Humans / Male Language: En Journal: Circulation Year: 2023 Document type: Article